Income Statement
ALLOGENE THERAPEUTICS, INC.
ALLO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
0.00 | 0.10 | 0.10 | 0.24 | 38.50 | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - |
|
Gross Profit
|
- | 0.10 | 0.10 | 0.24 | 38.50 | - | - | - |
|
Operating Expenses
|
209.32 | 273.22 | 327.83 | 335.69 | 294.28 | 258.24 | 202.01 | 192.84 |
|
Research & Development
|
150.15 | 192.30 | 242.91 | 256.39 | 220.18 | 192.99 | 144.54 | 151.86 |
|
Selling, General & Administrative
|
56.78 | 65.21 | 71.67 | 79.31 | 74.11 | 65.26 | 57.47 | 40.98 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - |
|
Operating Income
|
-209.32 | -273.12 | -327.73 | -335.45 | -255.78 | -258.24 | -202.01 | -192.84 |
|
Non-Operating Income
|
18.43 | 16.05 | 0.47 | 2.82 | -1.21 | 8.02 | 17.08 | -18.78 |
|
Interest Income
|
- | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | 0.00 | 0.00 | 3.36 |
|
Other Non-Op Income / Expense
|
0.22 | -3.92 | -17.84 | -1.75 | 1.71 | 9.16 | 17.35 | 5.79 |
|
Income Before Tax
|
-190.89 | -257.15 | - | - | -257.01 | -250.22 | -184.93 | -211.62 |
|
Income Tax Expense
|
0.00 | 0.44 | - | - | 0.00 | 0.00 | -0.33 | -0.12 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - |
|
Net Income
|
-190.89 | -257.59 | -327.27 | -332.63 | -257.01 | -250.22 | -184.59 | -211.51 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - |
|
EBITDA
|
-196.92 | -259.48 | -327.73 | -335.45 | -255.78 | -258.24 | -202.01 | -191.79 |
|
Earnings Per Share (Basic)
|
-0.87 | -1.32 | -2.09 | -2.32 | -1.89 | - | - | - |
|
Diluted EPS
|
-0.87 | -1.32 | -2.09 | -2.32 | -1.89 | - | - | - |
|
Weighted Average Shares
|
220.62 | 194.81 | 156.93 | 143.15 | 135.82 | - | - | - |
|
Diluted Weighted Avg Shares
|
220.62 | 194.81 | 156.93 | 143.15 | 135.82 | - | - | - |
|
Comprehensive Income
|
-190.53 | -256.72 | -318.29 | -339.99 | -259.84 | -251.10 | -183.76 | -211.20 |